<VariationArchive RecordType="classified" VariationID="11642" VariationName="NM_006517.5(SLC16A2):c.1613del (p.Pro538fs)" VariationType="Deletion" Accession="VCV000011642" Version="3" NumberOfSubmissions="2" NumberOfSubmitters="2" DateLastUpdated="2022-10-08" DateCreated="2013-04-04" MostRecentSubmission="2022-10-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="26681" VariationID="11642">
      <GeneList>
        <Gene Symbol="SLC16A2" FullName="solute carrier family 16 member 2" GeneID="6567" HGNC_ID="HGNC:10923" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>Xq13.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="74421493" stop="74533916" display_start="74421493" display_stop="74533916" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="73641327" stop="73753763" display_start="73641327" display_stop="73753763" Strand="+" />
          </Location>
          <OMIM>300095</OMIM>
          <Haploinsufficiency last_evaluated="2012-06-28" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC16A2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2012-06-28" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=SLC16A2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_006517.5(SLC16A2):c.1613del (p.Pro538fs)</Name>
      <CanonicalSPDI>NC_000023.11:74531544:CC:C</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>Xq13.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="X" Accession="NC_000023.11" start="74531545" stop="74531545" display_start="74531545" display_stop="74531545" variantLength="1" positionVCF="74531544" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="X" Accession="NC_000023.10" start="73751380" stop="73751380" display_start="73751380" display_stop="73751380" variantLength="1" positionVCF="73751379" referenceAlleleVCF="AC" alternateAlleleVCF="A" />
      </Location>
      <ProteinChange>P538fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.10" sequenceAccession="NC_000023" sequenceVersion="10" change="g.73751381del" Assembly="GRCh37">
            <Expression>NC_000023.10:g.73751381del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000023.11" sequenceAccession="NC_000023" sequenceVersion="11" change="g.74531546del" Assembly="GRCh38">
            <Expression>NC_000023.11:g.74531546del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011641.1" sequenceAccession="NG_011641" sequenceVersion="1" change="g.115297del">
            <Expression>NG_011641.1:g.115297del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_011641.2" sequenceAccession="NG_011641" sequenceVersion="2" change="g.115297del">
            <Expression>NG_011641.2:g.115297del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_006517.5" sequenceAccession="NM_006517" sequenceVersion="5" change="c.1613del" MANESelect="true">
            <Expression>NM_006517.5:c.1613del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_006508.2" sequenceAccession="NP_006508" sequenceVersion="2" change="p.Pro538fs">
            <Expression>NP_006508.2:p.Pro538fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA341128" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="300095.0011" DB="OMIM" />
        <XRef Type="rs" ID="113994166" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_006517.5(SLC16A2):c.1613del (p.Pro538fs) AND Allan-Herndon-Dudley syndrome" Accession="RCV000012408" Version="19">
        <ClassifiedConditionList TraitSetID="3177">
          <ClassifiedCondition DB="MedGen" ID="C0795889">Allan-Herndon-Dudley syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2006-05-01" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2006-05-01" NumberOfSubmissions="2" NumberOfSubmitters="2" DateCreated="2013-04-04" MostRecentSubmission="2022-10-01">
        <ReviewStatus>no assertion criteria provided</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">8484404</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15980113</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301789</ID>
          <ID Source="BookShelf">NBK26373</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="3177" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="148" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Allan-Herndon syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Monocarboxylate transporter-8 deficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Triiodothyronine resistence</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">T3 resisitence</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">X-linked mental retardation with hypotonia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Mental retardation and muscular atrophy</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">MCT8 (SLC16A2)-Specific Thyroid Hormone Cell Transporter Deficiency</ElementValue>
                <XRef ID="NBK26373" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">MCT8-Specific Thyroid Hormone Cell-Membrane Transporter Deficiency</ElementValue>
                <XRef ID="NBK26373" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Preferred">Allan-Herndon-Dudley syndrome</ElementValue>
                <XRef ID="Allan-Herndon-Dudley+Syndrome/306" DB="Genetic Alliance" />
                <XRef ID="MONDO:0010354" DB="MONDO" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">T3 RESISTANCE</ElementValue>
                <XRef Type="MIM" ID="300523" DB="OMIM" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">TRIIODOTHYRONINE RESISTANCE</ElementValue>
                <XRef Type="MIM" ID="300523" DB="OMIM" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">AHDS</ElementValue>
                <XRef Type="MIM" ID="300523" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Allan-Herndon-Dudley syndrome (AHDS), an X-linked disorder, is characterized in males by neurologic findings (hypotonia and feeding difficulties in infancy, developmental delayÂ / intellectual disability ranging from mild to profound) and later-onset pyramidal signs, extrapyramidal findings (dystonia, choreoathetosis, paroxysmal movement disorder, hypokinesia, masked facies), and seizures, often with drug resistance. Additional findings can include dysthyroidism (manifest as poor weight gain, reduced muscle mass, and variable cold intolerance, sweating, elevated heart rate, and irritability) and pathognomonic thyroid test results. Most heterozygous females are not clinically affected but may have minor thyroid test abnormalities.</Attribute>
                <XRef ID="NBK26373" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="5617" />
                <XRef ID="5617" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301789</ID>
                <ID Source="BookShelf">NBK26373</ID>
              </Citation>
              <XRef ID="59" DB="Orphanet" />
              <XRef ID="C0795889" DB="MedGen" />
              <XRef ID="MONDO:0010354" DB="MONDO" />
              <XRef Type="MIM" ID="300523" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="32642" SubmissionDate="2017-06-15" DateLastUpdated="2017-06-20" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="300095.0011_ALLAN-HERNDON-DUDLEY SYNDROME" title="SLC16A2, 1-BP DEL, 1834C_ALLAN-HERNDON-DUDLEY SYNDROME" />
        <ClinVarAccession Accession="SCV000032642" DateUpdated="2017-06-20" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2006-05-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In affected members of a large Brazilian family with Allan-Herndon-Dudley syndrome (AHDS; 300523), originally reported by Passos-Bueno et al. (1993), Maranduba et al. (2006) identified a 1-bp deletion (1834delC) in the SLC16A2 gene. The deletion is predicted to result in a frameshift and abnormal C terminus with an additional 64 amino acids. Serum T3 and free T3 levels were elevated in all affected males, whereas normal levels were found among obligate female carriers. In vitro functional expression studies suggested that the mutant protein results in decreased cellular T3 uptake and intracellular T3 metabolism. Maranduba et al. (2006) suggested that the severe neurologic defects in these patients result from deficiency of intracellular T3 and altered T3 metabolism in central neurons. In addition, the severe muscle hypoplasia observed may also result from high serum T3.</Attribute>
              <Citation>
                <ID Source="PubMed">8484404</ID>
              </Citation>
              <Citation>
                <ID Source="PubMed">15980113</ID>
              </Citation>
              <XRef DB="OMIM" ID="300523" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="SLC16A2" />
          </GeneList>
          <Name>SLC16A2, 1-BP DEL, 1834C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP DEL, 1834C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="300095.0011" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">ALLAN-HERNDON-DUDLEY SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="41179" SubmissionDate="2013-01-08" DateLastUpdated="2022-10-01" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="NM_006517.3:c.1834delC_NBK26373" title="NM_006517.3:c.1834delC and MCT8 (SLC16A2)-Specific Thyroid Hormone Cell Transporter Deficiency" />
        <ClinVarAccession Accession="SCV000041179" DateUpdated="2022-10-01" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation Type="general">
            <ID Source="PubMed">20301789</ID>
          </Citation>
          <Citation Type="general">
            <ID Source="BookShelf">NBK26373</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>unknown</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <Purpose>Assert pathogenicity</Purpose>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <XRefList>
            <XRef DB="dbSNP" ID="113994166" />
          </XRefList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_006517.3:c.1834delC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0795889" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="32642" TraitType="Disease" MappingType="Name" MappingValue="ALLAN-HERNDON-DUDLEY SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0795889" Name="Allan-Herndon-Dudley syndrome" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="41179" TraitType="Disease" MappingType="XRef" MappingValue="C0795889" MappingRef="MedGen">
        <MedGen CUI="C0795889" Name="Allan-Herndon-Dudley syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

